As Cerner (CERN) Share Price Declined, Shareholder Ontario Teachers Pension Plan Board Decreased Position; Gilead Sciences (GILD) Holder Krensavage Asset Management Has Decreased Its Position by $3.04 Million as Stock Price Rose

May 18, 2018 - By Hazel Jackson

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Ontario Teachers Pension Plan Board decreased its stake in Cerner Corp (CERN) by 23.7% based on its latest 2017Q4 regulatory filing with the SEC. Ontario Teachers Pension Plan Board sold 5,643 shares as the company’s stock declined 14.44% with the market. The institutional investor held 18,169 shares of the edp services company at the end of 2017Q4, valued at $1.22M, down from 23,812 at the end of the previous reported quarter. Ontario Teachers Pension Plan Board who had been investing in Cerner Corp for a number of months, seems to be less bullish one the $20.31 billion market cap company. The stock increased 0.99% or $0.6 during the last trading session, reaching $61.22. About 3.70 million shares traded or 27.24% up from the average. Cerner Corporation (NASDAQ:CERN) has declined 2.77% since May 18, 2017 and is downtrending. It has underperformed by 14.32% the S&P500.

Krensavage Asset Management Llc decreased its stake in Gilead Sciences Inc (GILD) by 8.23% based on its latest 2017Q4 regulatory filing with the SEC. Krensavage Asset Management Llc sold 42,871 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 478,053 shares of the health care company at the end of 2017Q4, valued at $34.25 million, down from 520,924 at the end of the previous reported quarter. Krensavage Asset Management Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $88.95 billion market cap company. The stock increased 1.20% or $0.81 during the last trading session, reaching $68.41. About 3.67M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since May 18, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Analysts await Cerner Corporation (NASDAQ:CERN) to report earnings on July, 26. They expect $0.55 EPS, down 1.79% or $0.01 from last year’s $0.56 per share. CERN’s profit will be $182.50M for 27.83 P/E if the $0.55 EPS becomes a reality. After $0.51 actual EPS reported by Cerner Corporation for the previous quarter, Wall Street now forecasts 7.84% EPS growth.

More notable recent Cerner Corporation (NASDAQ:CERN) news were published by: Globenewswire.com which released: “VA, Cerner Announce Agreement to Provide Seamless Care for Veterans” on May 17, 2018, also Benzinga.com with their article: “24 Stocks Moving In Friday’s Pre-Market Session” published on May 18, 2018, Globenewswire.com published: “Mayo Regional Hospital Selects Cerner CommunityWorks” on May 08, 2018. More interesting news about Cerner Corporation (NASDAQ:CERN) were released by: Bizjournals.com and their article: “Report: Cerner ranks No. 1 for global market share, more than double No. 2” published on May 16, 2018 as well as Nasdaq.com‘s news article titled: “Cerner and Uniform Data System for Medical Rehabilitation Create Standardized Integration” with publication date: May 15, 2018.

Ontario Teachers Pension Plan Board, which manages about $8.12 billion US Long portfolio, upped its stake in Spdr Series Trust (XBI) by 20,000 shares to 200,000 shares, valued at $16.97 million in 2017Q4, according to the filing. It also increased its holding in Phillips 66 (NYSE:PSX) by 6,421 shares in the quarter, for a total of 155,082 shares, and has risen its stake in Carnival Corp (NYSE:CCL).

Investors sentiment increased to 1.05 in Q4 2017. Its up 0.07, from 0.98 in 2017Q3. It is positive, as 42 investors sold CERN shares while 217 reduced holdings. 78 funds opened positions while 194 raised stakes. 251.96 million shares or 4.52% less from 263.89 million shares in 2017Q3 were reported. Los Angeles Management And Equity has invested 0% in Cerner Corporation (NASDAQ:CERN). Meag Munich Ergo Kapitalanlagegesellschaft Mbh holds 0.04% or 15,086 shares. 1,121 are owned by Acadian Asset Management Ltd Liability. Lau Assoc Limited Liability Com holds 20,050 shares. Vantage Investment Ltd Co, Pennsylvania-based fund reported 58 shares. Oakbrook Invs Ltd Com owns 4,950 shares for 0.02% of their portfolio. Mitsubishi Ufj Securities Ltd accumulated 150 shares or 0.04% of the stock. Amica Retiree Med stated it has 0.1% in Cerner Corporation (NASDAQ:CERN). Gw Henssler & Assoc Ltd stated it has 191,625 shares. Bridges Inv Mgmt invested in 10,575 shares. Notis stated it has 3,000 shares or 0.12% of all its holdings. Citigroup Inc owns 105,980 shares. Loring Wolcott & Coolidge Fiduciary Advsr Ltd Liability Partnership Ma accumulated 4,579 shares. Hartford Investment Mgmt invested in 100,975 shares. Financial Architects reported 165 shares.

Since December 13, 2017, it had 0 insider purchases, and 5 insider sales for $38.05 million activity. BURKE ZANE M had sold 50,000 shares worth $3.50 million on Wednesday, December 13. Battaglioli Michael R. had sold 4,000 shares worth $279,560 on Wednesday, December 13. TOWNSEND JEFFREY A sold $14.25 million worth of stock or 230,000 shares.

Among 29 analysts covering Cerner Corporation (NASDAQ:CERN), 15 have Buy rating, 0 Sell and 14 Hold. Therefore 52% are positive. Cerner Corporation had 115 analyst reports since August 5, 2015 according to SRatingsIntel. The company was maintained on Thursday, May 3 by KeyBanc Capital Markets. Cantor Fitzgerald maintained the stock with “Overweight” rating in Wednesday, February 7 report. The stock has “Neutral” rating by Hilliard Lyons on Tuesday, May 2. The stock of Cerner Corporation (NASDAQ:CERN) earned “Equal Weight” rating by Barclays Capital on Thursday, January 19. The firm earned “Buy” rating on Monday, December 18 by Cantor Fitzgerald. The stock of Cerner Corporation (NASDAQ:CERN) earned “Buy” rating by Deutsche Bank on Tuesday, November 10. The stock of Cerner Corporation (NASDAQ:CERN) earned “Buy” rating by Cantor Fitzgerald on Thursday, May 10. The rating was maintained by Jefferies on Tuesday, July 4 with “Buy”. The rating was maintained by SunTrust on Wednesday, February 7 with “Hold”. The company was downgraded on Tuesday, February 23 by Goldman Sachs.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on July, 25. They expect $1.43 EPS, down 43.03% or $1.08 from last year’s $2.51 per share. GILD’s profit will be $1.86B for 11.96 P/E if the $1.43 EPS becomes a reality. After $1.37 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts 4.38% EPS growth.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It worsened, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Nippon Life Global Americas owns 319,126 shares or 1.82% of their US portfolio. Nichols And Pratt Advisers Limited Liability Partnership Ma invested 0.97% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). S&Co accumulated 0.05% or 5,809 shares. Blb&B Limited Liability Company stated it has 0.05% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Convergence Inv Limited Liability Com holds 0.9% or 94,058 shares. 1.46 million were accumulated by Adage Prtnrs Group Incorporated Ltd Co. Bp Public Ltd Company holds 185,000 shares. Ledyard Bancorp accumulated 14,290 shares. Glg Partners L P, a United Kingdom-based fund reported 11,646 shares. Smithfield Communication has invested 0.04% in Gilead Sciences, Inc. (NASDAQ:GILD). Caisse De Depot Et Placement Du Quebec invested in 0.3% or 1.81M shares. Norinchukin National Bank The holds 0.21% or 171,334 shares. Cobblestone Capital Advsr Lc New York reported 62,265 shares. Winch Advisory Services Ltd Liability Corp reported 73 shares. 11,927 were accumulated by Orleans Cap Mgmt Corporation La.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “FDA OKs expanded use for Gilead’s Truvada” on May 15, 2018, also Bizjournals.com with their article: “2 big Bay Area companies look to map, tackle inflammatory diseases” published on April 30, 2018, Seekingalpha.com published: “AbbVie’s Mavyret Could Punish Gilead Tuesday” on April 30, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Gilead: What A Disaster” published on May 08, 2018 as well as Seekingalpha.com‘s news article titled: “Gilead Sciences: Resist Sentiment, Stop Speculating And Invest” with publication date: May 15, 2018.

Since January 2, 2018, it had 0 insider buys, and 22 sales for $44.80 million activity. 5,836 shares were sold by Cogan John Francis, worth $379,885 on Friday, May 4. Alton Gregg H had sold 25,000 shares worth $1.97M on Thursday, March 1. The insider Washington Robin L sold 5,000 shares worth $401,566. $4.68M worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares were sold by WILSON GAYLE E. Meyers James R also sold $8.02 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, January 16.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.